Month: June 2024

Bioanalytical Testing Services Market will Reach USD 8.51 Billion by 2031 | SkyQuest

Written by Customer Service on June 14, 2024. Posted in Mergers And Acquisitions.

Westford USA, June 14, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that Bioanalytical Testing Services Market will attain a value of USD 8.51 Billion by 2031, with a CAGR of 15% over the forecast period (2024-2031). The main reason behind the growth of this market is the recent tendency by major pharmaceutical firms to subcontract out their research and development (R&D) activities so they can focus on their main competencies. Additionally, during the estimated period, there will be high demand levels as it is cheaper when a study is done outside other than internally. It is anticipated that innovation and the creation of new products will increase demand for these services even more. Companies are outsourcing these services due to pressure from the competition and pricing concerns. Download a detailed overview: https://www.skyquestt.com/sample-request/bioanalytical-testing-services-market Browse...

Rail Vision Installed its AI-Driven Product with Loram, a Top US-Based Railway Track Maintenance Supplier

Written by Customer Service on June 14, 2024. Posted in Public Companies.

Ra’anana, Israel, June 14, 2024 (GLOBE NEWSWIRE) — Rail Vision Ltd. (Nasdaq: RVSN) (the “Company”), a technology company at the forefront of revolutionizing railway safety and the data-related market, today announced the successful delivery and installation of its AI-driven Shunting Yard product to Loram, a leading US-based provider of railway track maintenance equipment and services. This installation fulfills the purchase order announced on April 3, 2024, and marks the beginning of a pilot project aimed at enhancing Loram’s rail track maintenance operations with Rail Vision’s advanced technology. Pending a successful pilot completion, the two companies will consider an expansion of this product, further integrating Rail Vision’s innovative solutions into Loram’s rail vehicles across the United States. The Shunting...

McEwen Mining Announces Closing of Flow-Through Financing

Written by Customer Service on June 14, 2024. Posted in Public Companies.

TORONTO, June 14, 2024 (GLOBE NEWSWIRE) — McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) (“McEwen”) is pleased to report it has closed the previously announced public financing for US$22.0 million (Cdn$30.0 million) to fund ongoing exploration and development at the Fox Complex in the Timmins region of Ontario, primarily focused on exploration drilling and the development of an underground access ramp from surface to mine the gold resources of Stock East and West. This represents the next area of production growth at the Fox Complex. The proceeds of this financing will be used exclusively for qualifying Canadian Exploration Expenses (within the meaning of subsection 66.1(6) of the Income Tax Act (Canada)) (“CEE”) and Canadian Development Expenses (within the meaning of subsection 66.2(5) of the Income Tax Act (Canada)) (“CDE”), including: Part...

OneMedNet Partners with Leading Clinical Trial Design and Software Company in Significant Data License Agreement

Written by Customer Service on June 14, 2024. Posted in Public Companies.

Partner’s software products and services are utilized by hundreds of life science organizations, including the top 30 biopharmaceutical companies MINNEAPOLIS, June 14, 2024 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data (“RWD”), inclusive of electronic health records, laboratory results and, uniquely, medical imaging, announced today that it has entered into a iRWD™ Customer Data License (the “Agreement”) with an undisclosed U.S.-based global leader in clinical trial design and software. Pursuant to the Agreement, OneMedNet will utilize its proprietary iRWD™ platform to securely search, de-identify and curate current, regulatory-grade clinical data for the new customer, including its world-wide subsidiaries and affiliates,...

Monte Rosa Therapeutics Presents Preclinical Data at EULAR 2024 Demonstrating Therapeutic Potential of MRT-6160 for the Treatment of Rheumatoid Arthritis

Written by Customer Service on June 14, 2024. Posted in Public Companies.

MRT-6160, a VAV1-directed molecular glue degrader (MGD), inhibits disease progression, pro-inflammatory cytokines and autoantibody production in a model of rheumatoid arthritis Initiation of MRT-6160 Phase 1 SAD/MAD study anticipated in mid-year 2024 with initial clinical data expected in Q1 2025 Poster presentation today at 14:45 CET / 8:45 a.m. ET  BOSTON, June 14, 2024 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced the company will present preclinical data at the European Alliance of Associations for Rheumatology (EULAR) 2024 Congress, being held June 12-15 in Vienna, Austria. The data demonstrated that in a collagen-induced arthritis (CIA) murine model, oral dosing of MRT-6160 inhibited disease...

Big Data Analytics Market to Excel USD 845.97 Billion by 2031 | SkyQuest

Written by Customer Service on June 14, 2024. Posted in Mergers And Acquisitions.

Westford USA, June 14, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that Big Data Analytics Market will attain a value of USD 845.97 Billion by 2031, with a CAGR of 13.40% over the forecast period (2024-2031). Advanced big data analytics, which help enterprises comply with current platform-based models while keeping important information, allow the roles associated with performance monitoring and expenditure containment to be executed with greater efficiency on a larger scale, once data have been sent for storage. Furthermore, advanced analytics projects comprising learning applications, predictive analysis, and data mining are the main uses of the expanding, large data ecosystem. It therefore offers more flexibility for data processing, collecting, and analysis than conventional database systems such as data warehouses and relational...

Progressive Reports May 2024 Results

Written by Customer Service on June 14, 2024. Posted in Earnings Releases And Operating Results.

MAYFIELD VILLAGE, OHIO, June 14, 2024 (GLOBE NEWSWIRE) — The Progressive Corporation (NYSE:PGR) today reported the following results for the month ended May 31, 2024: May(millions, except per share amounts and ratios; unaudited) 2024Net premiums written $ 5,975.1Net premiums earned $ 5,857.5Net income $ 235.7Per share available to common shareholders $ 0.40Total pretax net realized gains (losses) on securities $ 117.6Combined ratio – current year 100.4 – prior year month 99.0Average diluted equivalent common shares 587.4In October 2023, we converted our monthly accounting closing calendar to align with the Gregorian calendar. We do not expect that this change will have a material impact on our reported quarterly and annual underwriting results but it may impact our year-over-year...

Aktsiaselts Infortar signed an agreement for selling a shareholding at subsidiary

Written by Customer Service on June 14, 2024. Posted in Public Companies.

On June 14, 2024, Aktsiaselts Infortar and Apteegikaubanduse Hulgimüük OÜ signed a share purchase agreement for selling 80% shareholding in the subsidiary Farmatar OÜ. This transaction marks Infortar exit from the wholesale of pharmaceuticals and pharmacy goods business segment. Following the transaction, Apteegikaubanduse Hulgimüük OÜ will become the new owner of the 80% shareholding in Farmatar OÜ. The transaction is not treated as a transaction beyond everyday economic activities or a transaction of a significant importance, nor as a transaction with related persons, within the meaning of the “Requirements for Issuers” part of the NASDAQ Tallinn Stock Exchange rules. The transaction does not have a significant impact on Aktsiaselts Infortar’s activities. The members of the Supervisory Board and the Management Board...

Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market

Written by Customer Service on June 14, 2024. Posted in Public Companies.

LONDON, June 14, 2024 (GLOBE NEWSWIRE) — Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced the pricing of an underwritten offering of 12,531,300 of its American Depositary Shares (“ADSs”). Each ADS is being sold at a price of $3.99 per ADS in an underwritten registered direct offering priced at-the-market under Nasdaq rules. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $50.0 million. Each ADS represents five ordinary shares of Mereo. The net proceeds of this offering are expected to be used to fund the setrusumab program, including supply and pre-launch activities in Europe, and for working capital and other general corporate...

Subsea7 awarded a contract for the Bittern field in the UK North Sea

Written by Customer Service on June 14, 2024. Posted in Public Companies.

Luxembourg – 14 June 2024 – Subsea7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced the award of a sizeable1 contract by Dana Petroleum (E&P) Limited, for the Bittern field development, located approximately 190km east of Aberdeen in the UK Central North Sea, at a water depth of 90 metres. The contract scope includes project management, engineering, procurement, construction and installation (EPCI) of a 22km 12” water injection pipeline. Subsea7’s scope also includes associated subsea structures and tie-ins at the Triton Floating Production Storage & Offloading (FPSO) vessel and the Bittern field. Project management and engineering work will commence immediately in Aberdeen. The offshore activities are scheduled for Q3 2025. Steve Wisely, Senior Vice President of UK and Global Inspection, Repair and Maintenance, Subsea7,...

Month: June 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals